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Abstract.  The progesterone receptor has been local- 
ized in the rabbit uterus by immunocytochemistry at 
the electron microscopic level, using monoclonal anti- 
bodies and the protein A-gold technique. The proges- 
terone receptor in uterine stromal cells was mainly 
localized in the nucleus; however, a small fraction of 
antigen was present in the cytoplasm, where it was 
associated with the rough endoplasmic reticulum and 
with free ribosomes. The plasma membrane was not 
labeled. In the nucleus, the receptor was always associ- 
ated with condensed chromatin or areas surrounding 
condensed chromatin, whereas the nuceolus was not 
labeled. In the chromatin, receptor distribution varied 
according to the hormonal state: in the absence of 
progesterone, the receptor was randomly scattered 
over the clumps of condensed chromatin; after admin- 
istration of the progestin R5020, it was mainly de- 
tected in the border regions between condensed chro- 
matin and nucleoplasm and, to a lesser extent, over 
dispersed chromatin in the nucleoplasm. These areas 
have been shown to be the most active sites of gene 
transcription. 
I 
N  target  cells,  steroid  hormones  form  complexes with 
specific receptors which in turn modulate gene expression 
(for review,  see reference 10). Data have recently accu- 
mulated  on  the  binding  of steroid-receptor complexes  to 
regulatory regions  of cloned genes (34).  However, little is 
known about the topology of these regulations in the intact 
cell.  The  recent availability of monoclonal antibodies  has 
allowed the study of the estrogen receptor by immunocyto- 
chemical  methods  at  the  light  microscope  level  (19,  29). 
Surprisingly, and in  contrast to results of cell  fractionation 
experiments, the receptor was found only in the nucleus, both 
in presence and in absence of hormone. Using monoclonal 
antibodies against the rabbit progesterone receptor (PR) ~  (25) 
and immunocytochemistry we have found a similar localiza- 
tion (35). These parallel findings suggest that all (or most) of 
the steroid receptors can be found in the nuclei of their target 
cells, even in the absence of their ligand. 
However, the exclusively intranuclear distribution of ste- 
roid  receptor antigen  found  at  the  light  microscopic level 
could not exclude the presence of small amounts of receptor 
in the cytoplasm, undetected at this level of resolution. More- 
over, the intranuclear distribution  of steroid receptors and 
their association with different nuclear structures (in the pres- 
ence or in the absence of hormone) remained unknown. 
The aim of the present study was to investigate the above- 
mentioned problems and thus,  for the first  time,  show the 
ultrastructural  localization  of a  steroid  hormone  receptor. 
Using monoclonal antireceptor antibodies and the protein A- 
gold technique (39), we observed that, in uterine stromal cells, 
,4hbreriation  used in this paper. PR, progesterone receptor. 
PR was located mainly in the nucleus, whereas only a small 
fraction was  present  at  specific  sites  in  the  cytoplasm.  In 
addition, immunoelectron microscopy of nontreated and pro- 
gestin-treated rabbits  revealed differences in  the  ultrastruc- 
rural distribution of immunoreactive PR within the nucleus. 
The observed redistribution was compatible with a  role for 
hormone-"activated" PR in the modulation of gene expres- 
sion. 
Materials and Methods 
Animals and Preparation of Tissues 
Immature female rabbits (New Zealand.  1 kg) were primed with estrogen as 
described (26).  30 min before being killed some rabbits received a subcutaneous 
injection  of  either  the  synthetic  progestin  R5020  (17,21-dimethyl-19-nor- 
pregna-4,9-diene-3,20-dione;  RousseI-Uclaf, Romainville, France) (10  mg in 
0.5 ml sesame oil), or of vehicle alone. The characteristics of these hormonal 
treatments were selected to match previous biochemical (24-27) and immu- 
nocytochemical studies (35).  Western blot experiments have shown  that  30 
min after such a progestin injection only 10-20% of receptor molecules remain 
in the cytosol (23).  The  ultrastructural distribution of progesterone receptor 
was compared in these two situations, which differ by the fact that receptor is 
either unliganded or bound to the hormone. 
Rabbit uteri were removed immediately after cervical dislocation. For con- 
trol in light microscopy, a  slice (2 mm  long) was taken in the middle part of 
the  uterus,  fixed in  1%  glutaraldehyde, and embedded  in  paraffin (35).  For 
electron microscopy, fragments (_<1 mm  3) from endometrium or myometrium 
were fixed with  1% glutaraldehyde in Sorensen buffer, pH  7.4,  for 6 h at 4°C. 
Occasionally, free aldehyde groups were blocked by subsequent incubation of 
fragments in 0.5 M  NH4C1 in phosphate buffer for 1 h (38).  Postfixation with 
OsO4 was omitted. Dehydration through an ethanol series at 4"C,  infiltration 
with propyleneoxyde, and embedding in Epon 812 were performed according 
to the usual procedure. Semithin sections, 0.5 gm thick, were obtained from 
these blocks and mounted on glass slides. Thin sections  were cut with a diamond 
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labeling. 
Antisera 
Monoclonal  mouse IgG against PR  from rabbit uterus (Mi60-10  alone or a 
mixture of Mi60-10,  Mil 1-5, Mi5-31,  Mil-2) was used for immunolabeling in 
electron microscopy, as it had been for previous light microscopic studies (35). 
The specificity  studies of these antibodies have been described (24,  25,  27). 
They included density-gradient experiments (25), precipitation of 3H-progestin- 
PR  complexes with  a  second  antibody  or  protein  A  (25),  immunoblotting 
analysis of crude uterine cellular extracts (27), and immunoaffinity chromatog- 
raphy experiments (24). 
Mouse monoclonal antibodies (IDA and AIDA, a girl from Dr. P. Legrain, 
lnslilul Pasteur, Paris), unrelated to the receptor under study, served as controls. 
They were antiidiotypic antibodies raised against mouse myeloma antilevan 
antibodies (21).  In all cases,  the control antibody was of the same class as the 
antireceptor  antibody  (for instance,  IgG~, class in  the  case of the  Mi60-10 
antibody). 
Immunocytochemical Labeling 
For light  microscopy, paraffin sections (4 um thick) or semithin sections of 
Epon-embedded uterus were stained by an indirect immunoperoxidase method 
or  by  the  peroxidase-antiperoxidase  method,  as  previously described  (35). 
Before the immunolabeling procedure, semithin sections were deplastified  with 
sodium ethoxide (20). 
For electron microscopy, PR was localized  on thin sections using the protein- 
A gold technique developed by Roth (39),  but the etching step with H202 was 
replaced  by a  treatment  with sodium metaperiodale  (4).  All  solutions were 
filtered  on 0.45-urn Millex filters (Millipore Corp., Bedford,  MA) immediately 
before use. Background labeling was reduced by incubating sections with 1% 
ovalbumin for 5 min before labeling and by using 0.05% Tween in all incuba- 
tions and  washes. In  brief,  grids were floated  on  a  drop of diluted  mouse 
monoclonal antibodies (Mi60-10,  1.5-3 #g/ml) in PBS containing 1% ovalbu- 
rain, for 3 h at room temperature in a  humid chamber. Then the grids were 
washed with PBS and incubated for I h with protein A conjugated to colloidal 
gold particles 15 nm in diameter (or 10 nm where indicated) (diluted  1:40 in 
PBS  containing  1%  ovalbumin)(Janssen  Pharmaceutica,  Beerse,  Belgium). 
After successive washings in PBS and distilled  water, the grids were air-dried. 
They were post-stained with uranyl acetate (4%  in distilled  water) for 5 min 
and viewed  in a  Siemens electron  microscope type CT 305  at 80 kV. Some 
sections were stained by the uranyI-EDTA-lead method of Bernhard (8) after 
immunogold labeling;  in this case,  sections were stained (2 min) with uranyl 
acetate,  layered on a 0.1 M EDTA solution for 20 min, and finally post-stained 
( 1 min) with lead citrate. 
Controls were prepared as follows. Several  dilutions of Mi60-10  antibodies 
(lgG2a class) were initially  studied (1.5-20 t~g/ml), and the dilutions used (1.5- 
3 ug/ml) were finally  selected  because they gave an optimal staining of proges- 
terone  receptor-containing nuclei  and a  low background over mitochondria 
and  extracytoplasmic  matrix. Control  tests,  which all  gave  negative  results, 
involved the substitution of monoclonal Mi60-10 antibodies either by a non- 
progesterone receptor-related  monoclonal antibody  of the  same class (IDA, 
lgGu)  used at  the same concentration,  or by monoclonal anti-progesterone 
receptor antibodies that had been adsorbed by the pure receptor (24) before the 
immunolabeling (35). 
For each hormonal situation, three rabbits, two randomly chosen blocks per 
uterus, and 4-10 grids per block were studied. A mean of 30 grids per situation 
were thus investigated  by the immunogold method,  using the same optimal 
concentration of antibodies. 
For the analysis of nuclear localization,  four nuclear compartments were 
considered: dense chromatin, chromatin border, interchromatin space or nu- 
cleoplasm (which contains dispersed chromatin and [nterchromatinic granules), 
and  nucleolus.  Dense chromatin was defined as the region bleached  by the 
EDTA reaction, and the chromatin border was arbitrarily defined as a 2,500  A 
wide zone, according to the description used for the analysis of transcription 
zones by Puvion and Moyne (36). 
Results 
Preliminary Immunocytochemical Studies at the 
Light Microscope Level 
We have previously described that,  at the light microscope 
level, the progesterone receptor is present in the nuclei of the 
target cells, even in the absence of hormone (35).  However, 
we did  not compare in detail its localization in  nontreated 
and hormone-treated animals. As shown in Fig.  1, a and b, 
immunocytochemical observations by light  microscopy do 
not allow the detection of any apparent change in  receptor 
distribution after hormone administration. To detect any such 
possible  effect  of the  hormone,  it  was  thus  necessary  to 
perform studies at the  electron  microscope level.  Since we 
planned  to  use thin  sections of Epon-embedded tissue  for 
these observations, it was necessary to eliminate the possibility 
that such experimental conditions could either provoke an 
artifactual redistribution of antigen or prevent the binding of 
antibody to receptor. Thus, semithin sections (0.5  urn) were 
prepared and treated by the immunocytochemical procedure 
(35).  Fig.  1 c  shows  that  this  change  in  tissue-embedding 
conditions does not modify receptor localization and does not 
suppress its antigenicity. 
Cellular Distribution of PR Observed at the 
Ultrastructural Level 
PR was detected in thin  sections of Epon-embedded uterus 
using the protein A-gold technique (39). Fixation of  the tissues 
with 1% glutaraldehyde without osmification resulted in good 
ultrastructural preservation of uterine cells. Specific  staining 
with Mi60-10 antibodies was revealed in all uterine cell types 
(luminal  and  glandular  epithelium,  stroma,  myometrium) 
previously shown to contain  PR immunoreactivity by light 
microscopy (35). Stromal fibroblasts, which are the cell type 
containing the higher concentration of receptor (see Fig.  1  a) 
were chosen for further studies on the intracellular distribu- 
tion of receptor in interphase nuclei and in the cytoplasm. As 
shown in Fig. 2, specific labeling for PR was present mainly 
in  the  nuclei  of these  target  cells.  Weak  labeling of some 
cytoplasmic structures was also observed in many sections at 
high magnification (see last section of Results). The plasma 
membrane was not labeled. 
Nuclear Localization of PR in the Absence 
of  Hormone 
In rabbits not treated with progestin, the major part of con- 
densed chromatin was organized in large clumps present at 
the periphery of  the nucleus, at the periphery of  the nucleolus, 
and sometimes apparently localized inside the nucleus. These 
structures were heavily and randomly labeled (Fig. 3, a and 
d). Smaller clumps of condensed chromatin were more lightly 
labeled, usually randomly but sometimes at their periphery. 
The  nucleoplasm  was  not  labeled  above background.  The 
only structure in the nucleolar region that was labeled was 
the perinucleolar condensed chromatin. 
The specificity of the immunogold staining was shown by 
controls made by (a) replacing antiprogesterone receptor an- 
tibodies by nonrelated  antibodies of the  same class,  at the 
same concentration (Fig. 3 c), (b) incubating the sections with 
the protein A-gold complex in absence of antibodies, or (c) 
preadsorbing the antibodies with pure progesterone receptor 
(Fig.  3 b). In all cases only a low background was observed, 
randomly distributed on all cellular structures and over the 
extracellular space. 
Furthermore, application of the EDTA regressive stain (8) 
results in  a  preferential staining of ribonucleoproteic struc- 
tures and thus allows us to distinguish them from chromatin. 
The Journal of Cell Biology, Volume 102, 1986  1 192 Figure  1.  Preliminary  experiments  at  the  light  microscope  level. (a  and  b)  Effect of hormone  administration  on  progesterone  receptor 
localization. (c) Effect of  tissue-embedding in Epon. Uteri from progestin-treated (b) and nontreated (a and c) rabbits were embedded in paraffin 
(a and b) or in Epon (c). For the detection of the receptor, sections were treated either by the indirect peroxidase-antiperoxidase method (a and 
b) or by the indirect peroxidase method using peroxidase-labeled rabbit IgG (c). Under all conditions, typical immunostaining is seen in cell 
nuclei of luminal and glandular epithelium (E) and stroma (S). Note the stronger staining in stromal cells as compared with epithelial cells. 
There was no counterstaining. Bar, 25 urn. 
When  this  method  was  applied  to  thin  sections  after  the 
immunogold staining, it clearly showed that the receptor was 
associated with  chromatin and  not  with ribonucleoproteins 
(Fig. 4). 
Nuclear Localization of  PR After Administration 
of  Progestin 
The intranuclear concentration and distribution of the recep- 
tor were changed in the uterine stromal cells of rabbits treated 
by progestin (R5020)  (Fig.  5).  The overall labeling was de- 
creased  by  hormone  treatment  (compare Figs.  3  and  5a). 
Such changes of receptor concentration have previously been 
observed in biochemical studies (18,  30) and have sometimes 
been called "receptor processing" (31 ) or "down regulation." 
Moreover, the general organization of the chromatin changed 
in these cells after the progestin was administered. The clumps 
of condensed chromatin became smaller and were spread out 
within the nucleus (see in Fig. 5 a). PR immunoreactivity was 
also associated with chromatin, as confirmed by the regressive 
EDTA technique (8). However, in contrast to what was seen 
in rabbits not treated by the progestin, the immunogold stain 
was spread out as was condensed chromatin. The decrease in 
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dered  the  interpretation  of its  distribution  more  difficult. 
However,  the  examination  of many  different  samples  (30 
grids) enabled us to define clearly its localization: gold parti- 
cles were  observed mainly at the border between the  small 
clumps of condensed chromatin and the nucleoplasm (Fig. 5, 
a  and  d).  Some  labeling was  also  present  over  dispersed 
chromatin  in  the  nucleoplasm  (Fig.  5c).  In  contrast,  the 
clusters of interchromatinic granules were not labeled above 
background. These granules were clearly visible after a stand- 
ard uranyl acetate staining. Occasionally, a  few gold particles 
were still associated with the remaining thin perinuclear (Fig. 
5 a)  and  perinucleolar (Fig.  5 e) condensed  chromatin.  The 
specificity  of the labeling was again established by the controls 
described above in the case of non-progestin-treated animals: 
nonspecific labeling with receptor unrelated monoclonal an- 
tibodies was very low (Fig. 5 b), and competitive inhibition of 
the staining by pure receptor was observed (not shown). 
Presence of a Small Amount of PR in the Cytoplasm 
of Target Cells 
At the light microscope level, immunocytochemical studies 
have  not  shown  any estrogen (19,  29)  or progesterone (35) 
receptors in the  cytoplasm. We took advantage of the  high 
Figure 2, Cellular distribution of progesterone receptor immunoreactivity observed at the ultrastructural level in endometrial stromal cells. 
Thin  sections of glutaraldehyde-fixed and  Epon-embedded uterus were  stained by the pAg technique (see Materials and Methods).  Gold 
particles revealing PR-immunoreactive sites are present mainly in the nucleus (N). The extracellular matrix (EM) is free of label. PM, plasma 
membrane. Nu, nucleolus.  Cyt, cytoplasm. Bar, 0.5 um. 
Figure 3. Nuclear localization of progesterone receptor in uterine stromal cells in the absence of hormone. Thin sections were incubated with 
antireceptor antibody (a and d) or control reagents (b and c). Counterstaining with uranyl was used. (a) With antireceptor antibody an intense 
labeling is present over clumps of condensed chromatin (CC) located at the periphery of the nucleus (N) (thin arrows) or apparently inside the 
nucleus (thick arrows). The nucleoplasm that contains the dispersed chromatin (DC) and ribonucleoproteic structures  was not labeled above 
background. (b) Incubation of sections in antireceptor antibody preabsorbed (35) with the pure antigen (24) results in a marked reduction of 
the labeling. (c) Very few gold particles are found over the different  nuclear structures when a monoclonal antibody not related to receptor 
(IDA3, IgGza)  was used. Protein A-gold alone gives an identically  weak staining. In d, protein A conjugated to  10-nm-diam gold particles was 
used, and micrographs of the nucleus were taken at a higher magnification.  The label is clearly associated with clumps of condensed chromatin. 
Bar, 0.5 urn. 
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stromal cells in the absence of hormone. Immunogold labeling of PR 
was followed by the EDTA regressive technique (8). The condensed 
chromatin (CC) appears bleached by the EDTA treatment, whereas 
ribonucleoproteic structures in the nucleoplasm, among them clusters 
of interchromatinic granules (IG), contrast well.  Most progesterone 
receptor  imrnunoreactivity  is  associated  with  bleached  condensed 
chromatin clumps. NM,  nuclear membrane.  M, mitochondria. Bar, 
0.5 um. 
resolution offered by the electron microscope to reexamine 
this question. Using the immunogold method, we have con- 
firmed that  the  vast  majority of receptor molecules were 
intranuclear,  either  in  the  absence  or  in  the  presence  of 
progestin (see Fig. 2). However, some immunogold staining, 
very clearly above background, was observed in the cytoplasm 
(Fig. 6). After progestin injection, gold particles were located 
along the membranes of the rough endoplasmic reticulum, 
mainly associated with ribosomes, and were also located over 
clusters of free ribosomes (Fig.  6 a).  The mitochondria, the 
Golgl apparatus,  and the lumen of the rough endoplasmic 
reticulum remained unlabeled. The labeling of the cytoplasm 
appeared  to  be  more  scattered in  animals  not  treated  by 
progestin. 
Discussion 
By light microscope immunocytochemistry  using monoclonal 
antibodies,  estrogen  and  progesterone receptors have been 
observed to reside in the nuclei of their target cells (19,  29, 
35).  In  contrast, different localizations of steroid hormone 
receptors (only cytoplasmic [16,  33,  37],  only nuclear [15], 
both cytoplasmic and  nuclear [1,  7,  14,  17], translocation 
from the cytoplasm to the nucleus after hormonal treatment 
[7,  16, 33, 37]) have been reported in other light immunocy- 
tochemical studies using polyclonal antibodies. Some of these 
discrepancies, especially when extranuclear localization was 
observed, might have been due to the fact that the polyclonal 
antibodies recognized not  only the receptor but also other 
antigens. 
The present study represents the first  visualization at the 
electron microscope level of a steroid receptor in a target cell 
using specific monoclonal antibodies. 
Various methodological difficulties had to be resolved to 
observe the in situ localization of PR. Previous immunocy- 
tochemical studies at the light microscopic level had already 
been in part focused on the determination of fixation condi- 
tions that thereafter could be used for ultrastructural immu- 
nocytochemistry. In this respect, the possibility  of detecting 
immunoreactive receptor after glutaraldehyde fixation proved 
to be important, since this fixative gives a good preservation 
of cellular ultrastructure. This, added to the use of the protein 
A-gold  technique,  has  allowed a  fine identification of the 
labeled nuclear and cytoplasmic structures. Due to their high 
electron  density,  gold  particles  are  easily  detected  in  the 
electron microscope and, in contrast to the peroxidase-anti- 
peroxidase technique, do not obscure the ultrastructural de- 
tails  of the labeled structures. The fixation and embedding 
conditions used probably did not lead to an artifactual redis- 
tribution of the antigen for the following reasons:  glutaralde- 
hyde rapidly penetrates cells  and  cross-links  proteins; and 
consistent and unequivocal staining of PR with little or no 
background was constantly observed in the numerous exper- 
iments (30 different grids;  see Materials and Methods). We 
are now examining the possibility of using other fixatives, but 
this necessitates long preliminary studies.  In each case,  it is 
necessary to define the precise experimental conditions that 
give  a  good  preservation of ultrastructural details  without 
impeding the immunological recognition of the receptor. 
The specificity of  the antireceptor antibodies has previously 
been thoroughly discussed (24, 25, 27). The same localization 
of PR immunoreactivity was observed using either Mi60-10 
monoclonal antibodies or a mixture of  four other monoclonal 
antibodies (35). In addition, a comparable result was obtained 
using  a  goat  polyclonal  monospecific  antibody  prepared 
against  the  purified (chromatographed on  immunoaffinity 
column [24], electrophoresed, and electroeluted) 110 kD form 
of PR (Logeat, F., unpublished observations). The absence of 
staining by gold-protein A  alone, or by receptor unrelated 
monoclonal antibodies  or  presaturated  PR  antibodies  also 
indicates the specificity of the immunocytochemical staining. 
Most  of the  PR  molecules were  intranuclear in  uterine 
stromal cells, as well as in epithelial, glandular, and smooth 
muscle cells (Perrot-Applanat, M., unpublished observations). 
In  stroma cells  and  in the absence of hormone, they were 
localized mainly in the condensed chromatin which is known 
to be for the most part transcriptionally inactive (12).  Since 
receptors are easily extracted when the tissue is homogenized, 
they  are  probably  loosely bound  to  some  component  of 
condensed chromatin. By contrast, after the administration 
of hormone, the relative labeling was increased at the border 
The Journal of  Cell Biology,  Volume 102. 1986  1196 Figure 5. Nuclear  localization of progesterone receptor  in uterine stromal cells after administration  of the progestin R5020. Note the more 
euchromatic appearance  of these nuclei (N). Progesterone receptor immunoreactivity  is observed over small clumps of condensed chromatin 
(CC), mainly at their periphery (a and d). (c) In nuclei exhibiting highly dispersed chromatin, labeling is also observed over dispersed chromatin 
(DC). (e) The nucleolus  (Nu) is not significantly labeled; Pnc, perinucleolar  chromatin.  (b) Control  incubation  with  non-receptor-related 
antibody.  Note the complete absence of immunocytochemical staining. IG, interchromatinic  granules. Bar, 0.5 urn. 
of dense chromatin and  nucleoplasm.  Some labeling corre- 
sponded to dispersed chromatin in  the  nucleoplasm.  These 
localizations  correspond  to  the  regions  known  to  be  most 
active in extranucleolar gene transcription (11,  12). Nash et 
al.  (32)  have  previously  shown  that  the  increase  of RNA 
synthesis in rat liver nuclei provoked by cortisol was correlated 
with  the  increase  of the  amount  of perichromatin  fibrils 
localized at the periphery of condensed chromatin.  In addi- 
tion, it has been shown that the newly transcribed RNA seems 
to  be  closely associated  with  the  nuclear  matrix  (5).  Also, 
biochemical studies have indicated that various steroid hor- 
mone receptors may be  associated  with  the  nuclear  matrix 
(2). 
This  description  of receptor distribution  is  based  on  the 
analysis of a total of 12 different blocks, obtained from three 
progestin-treated  and  three  nontreated  rabbits,  and the  ex- 
amination of >200 electron micrographs. It is also supported 
by preliminary  manual  counts of the  immunogold labeling 
(unpublished  observations).  Of course, these qualitative  ob- 
servations should be completed by a  quantitative evaluation 
Perrot-Applanat  et al. Progesterone  Receptor  1197 Figure 6, Presence of a small amount of progesterone receptor in the cytoplasm of uterine stromal cells. (a) Most of the gold particles appear 
located along the rough endoplasmic reticulum (rER) membranes or associated with clusters of free ribosomes (R). The labeling observed over 
mitochondria  (34) and  other  organelles in  the  cytoplasm is not  above background. (b) No labeling is detected when receptor-unrelated 
monoclonal antibodies (IDA) are used at the same concentration in adjacent thin sections. Bar, 0.5 ~m. 
of the distribution of the  labeling; we are now reexamining 
our micrographs with an automated image analyzer. 
The partial redistribution of the PR within the nucleus of 
stromal  cells  upon  administration  of hormone  may corre- 
spond  to  a  translocation  of the  receptor from  one  site to 
another.  Alternatively,  it  may be  due  to  the  fact that  the 
receptor simply accompanies the change in localization of at 
[east some specific genes. It is noticeable that, in stromal cells, 
the  administration  of the  progestin markedly decreases the 
proportion  of condensed  chromatin present in  the  form of 
large  clumps.  Thus,  specific  genes  initially  present  in  the 
condensed regions are probably shifted towards the euchro- 
matin  or  to  the  periphery  of condensed  chromatin.  If it 
interacts with these genes, the receptor may perhaps passively 
change its localization. Similar changes in the ultrastructure 
of target cell nuclei upon administration of steroid hormones 
have previously been described (6,  40,  42).  Thus,  estradiol 
transformed the  condensed  chromatin  into  dispersed chro- 
matin in uterine epithelial cells (6, 42). Moreover, as described 
in this study, dispersion of chromatin has also been observed 
in  rat stromal cells  under progesterone treatment (40).  The 
mechanism  of this  modification  of chromatin  structure  is 
unknown.  To  determine  whether  the  receptor translocates 
from one site to another or only changes its localization in a 
passive way, it would be necessary to localize in intact inter- 
phase nuclei specific hormonally regulated genes before and 
after hormone administration. 
In various uterine cell types, there seems to be a relationship 
between the importance of the change in the organization of 
the chromatin provoked by the steroid and the importance of 
receptor redistribution in the nucleus.  We have recently ex- 
amined the  distribution  of PR  in  myometrial cells.  As ob- 
served for stromal cells,  PR imunoreactivity was associated 
with condensed chromatin. However, progestin injection does 
not,  in  myometrial cells  (in  contrast  to  in  stromal  cells), 
provoke a  major change in chromatin structure (Perrot-Ap- 
planar, M., unpublished observations). Similarly, the redistri- 
bution  of receptor in  the  nucleus,  if it  follows  the  general 
pattern described above (receptor scattered over condensed 
chromatin in the absence of hormone, enhanced labeling at 
the border of condensed chromatin and nucleoplasm in the 
presence of hormone), appears to be less pronounced in the 
myometrial cells.  Now  that  the  methodology  is  available, 
ultrastructural localization studies with other receptors and in 
other target cells should reveal how general the present obser- 
vations are. 
Progesterone (and/or estradiol) have been shown to cause 
various effects in  stromal cells:  stimulation of cell  division 
(28),  an increase in rough endoplasmic reticulum (9). These 
cells, under proper stimuli and in the presence of progester- 
one, develop into decidual tissue (13). 
Various other questions are raised by this study: What is 
(are)  the  component(s)  of condensed  chromatin  to  which 
receptors are bound in the absence of hormone? Do hormone- 
receptor complexes interact only with accessible DNA, or do 
other features of the chromatin (spatial organization, specific 
proteins, etc.) also play a role? The localization of accessible 
DNA  in  the  nucleus  was  studied  by  Bendayan  (3)  using 
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conditions under which the enzyme bound to DNA without 
digesting  it.  In  Epon-embedded tissue,  most gold  particles 
were associated with dispersed chromatin. A comparison be- 
tween both studies suggests  that the distribution  of steroid- 
receptor complexes cannot  be simply explained by that  of 
accessible DNA. 
The presence of low, but clearly above background, labeling 
in the cytoplasm provides evidence of the existence of a small 
concentration of the receptor in this compartment, which was 
probably under the limit of detectability of the light micro- 
scope observation. This receptor is apparently associated with 
membrane-bound or free ribosomes. It may represent newly 
synthesized  protein  or,  alternatively,  it  may be  exerting  a 
biological function on the translational machinery of the cell. 
Biochemical evidence in favor of such a localization and such 
a role has been published (22, 41). 
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